In conjunction with The Cornea Society

Date: Saturday, Nov. 16

Time: 8 a.m. to 5:30 p.m.

Location: Morial Convention Center

Schedules

• 2013 Cornea Subspecialty Day Schedule (PDF 225KB)
• Online Program Search for Subspecialty Day courses and events will be available in June.

Registration and Hotel Reservations

• Registration and hotel reservations for Subspecialty Day meetings and the Annual Meeting opens for Academy members June 26, and nonmembers July 10.

Registration for the Cornea Subspecialty meeting allows you to:

• Visit the Annual Meeting Exhibit Hall on Saturday, Nov. 16.
• Float among all Subspecialty Day meetings held on Saturday, Nov. 16 – Cornea, Glaucoma, Neuro-Ophthalmology, Oculofacial Plastic Surgery, Pediatric Ophthalmology, Refractive Surgery and Retina.

Cornea Program

Program Directors
Kathryn A. Colby, MD, PhD; William Barry Lee, MD; Elmer Y. Tu, MD

Planning Group
Michael W. Belin, MD; Kathryn A. Colby, MD, PhD; David B. Glasser, MD; Donald Tan, MD, MBBS; William Barry Lee, MD; Elmer Y. Tu, MD

Mission Statement
The mission of the 2013 Cornea Subspecialty Day is to provide cornea specialists and comprehensive ophthalmologists who are actively managing patients with corneal diseases with new information regarding the diagnosis and medical and surgical management of important diseases of the cornea and ocular surface. The program will review evidence-based treatments for challenging medical disorders of the cornea, including corneal infections. Advances in the understanding and treatment of Fuchs corneal dystrophy will be presented. Surgical management of corneal disease will be highlighted in several formats, including didactic lectures, panel discussions and case presentations.

Target Audience
The intended audience for this program is cornea surgeons, comprehensive ophthalmologists with an interest in anterior segment, and allied health personnel who are performing or assisting with cornea surgery.

Education Level
Intermediate, Advanced

Goal
The goals of this program are to:

• Provide attendees with an evidence-based review of current management strategies for both commonplace and less common medical disorders of the cornea, including dry eye syndrome, infectious keratitis, graft rejection, and recurrent erosion, using a case-based approach to improve care of patients with these challenging diseases.
• Describe the current state of understanding of Fuchs dystrophy, including future directions for selective endothelial replacement and the best way to manage cataracts in this population.
• Describe the current state and future directions for various types of corneal transplant surgeries, including a discussion of how to overcome the various hurdles faced when adopting new techniques. This will be accomplished through lectures by respected experts as well as by surgically focused case presentations followed by panel discussions.
• Provide attendees with an update on collagen crosslinking, which is widely performed outside the United States and represents a major advance in our ability to manage ectatic diseases of the cornea, in order to raise awareness of how and when to recommend this treatment.

Program Objectives
Upon completion of this activity, participants should be able to:

• Describe the evidence-based approach to managing medical diseases of the cornea and ocular surface, including inflammatory, infectious, and degenerative conditions.
• Compare the advantages and disadvantages of recently popularized techniques of corneal transplantation (Descemet membrane endothelial keratoplasty, deep anterior lamellar keratoplasty, and keratoprosthesis) and understand strategies to incorporate these techniques into their practice.
• Discuss how changes in the health care system will impact the subspecialty of cornea.
• Describe how clinical trials and laboratory investigations can improve our treatment of Fuchs endothelial dystrophy. Recognize issues with cataract surgery in this population, thus allowing for improved outcomes.
• Identify patient groups for whom collagen crosslinking is a promising treatment and understand the advantages and disadvantages of different crosslinking techniques.

CME Accreditation
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Attendees registered as exhibitors, spouses, or guests are not eligible for CME credits.